Comparing Satisfaction With a Participatory Driven Web-application and a Standard Website

January 25, 2021 updated by: Allan Riis, Aalborg University Hospital

Comparing Satisfaction With a Participatory Driven Web-application and a Standard Website for Patients With Low Back Pain: a Study Protocol of a Randomised Controlled Trial

This project studies the effects of involving patients in the development of a web-application.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Detailed Description

The point-prevalence of low back pain (LBP) has been estimated to 9.4 % and LBP is in many countries the most frequent reason to consult a general practitioner. However, general practitioners are under pressure with increasing workloads. The increasing number of patients and the typical 10-15 minutes of available time for each patient are challenging the provision of sufficient information and advice. According to international guidelines information and advice are recommended for every patient with LBP, therefore, new methods to support general practitioners (GPs) are very much needed. Online technologies give new opportunities to extend the treatment. Furthermore, involving patients with LBP in the development of online information material may produce more user friendly content and design and thereby increasing patients' acceptance and usage. Thus, optimizing clinical outcome. This project will study patients' satisfaction and clinical outcomes of a web-application for patients with LBP consulted in general practice compared to best existing technology (the Patient Handbook).

Study Type

Interventional

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Contacting general practice with low back pain

Exclusion Criteria:

  • Spinal stenosis
  • Spine fractures
  • Cauda equina syndrome
  • Spinal malignancy
  • Osteoporosis
  • Spondyloarthritis
  • Without Danish reading skills
  • Without internet access
  • Pregnant women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: New web-application
Information material developed in a participatory design together with patients.
Online web-application developed together with patients with low back pain
Experimental: Patient Handbook
Public available information.
Online web-application developed together with patients with low back pain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
General satisfaction
Time Frame: 12 weeks
The question: 'how likely is it that you would recommend this web-application to a friend or colleague?' will be applied to measure satisfaction. The patients will be asked to choose between 11 boxes displayed on a horizontal line (10-0 Points, higher score indicating more satisfaction). The scales will be labelled to the left at 10 (extremely likely) and at the right side as 0 (not at all likely). It is only possible to tick off one box, if the patient change decision while filling in the online questionnaire, another box can be ticked off and the first choice will automatically delete. Responses of 10-9 are grouped as 'satisfied' of the web-application and patients replying 8-0 will be grouped as 'not satisfied'. The proportion of patients being satisfied after 12 weeks is the primary analysis. The proportion of patients being satisfied after 1, 2, 4, and 8 weeks will be carried out as secondary analyses.
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional improvement
Time Frame: 12 weeks
Roland Morris functional disability score (RMDQ, the Patrick version, 0-23 points)
12 weeks
Pain intensity
Time Frame: 1, 2, 4, 8, and 12 weeks
Numerical pain rating of current pain (0-10 Points, rating from 'no pain' to 'maximal pain' )
1, 2, 4, 8, and 12 weeks
Improvement in self-rated health
Time Frame: 12 weeks
EQ-5D-5L (EuroQol - 5 Diminsions - 5 Levels)
12 weeks
Employment status
Time Frame: 12 weeks
Self reported current employment status (yes/no)
12 weeks
Sick leave
Time Frame: 12 weeks
Self reported number of hours of sick leave during the study
12 weeks
Contacts to general practice
Time Frame: 12 weeks
Self reported number of general practice contacts since study inclusion
12 weeks
Contacts to primary care physiotherapists
Time Frame: 12 weeks
Self reported number of physiotherapy contacts since study inclusion
12 weeks
Contacts to primary care chiropractors
Time Frame: 12 weeks
Self reported number of chiropractor contacts since study inclusion
12 weeks
Contacts to secondary care
Time Frame: 12 weeks
Contact to secondary care because of low back pain during the study (yes/no)
12 weeks
Cost utility analysis
Time Frame: 12 weeks
A analysis comparing the intervention group with the control group from a healthcare perspective. Including primary care costs such as public paid costs for GP contacts, physiotherapy services, and chiropractic services. Quality adjusted life years (QALYs) will be applied as measure of effect based on EQ-5D-5L. We will not include costs for developing and maintaining the new technology or other protocol driven costs. Based on the relative short time-horizon costs and effects will not be discounted.
12 weeks
Specific satisfaction
Time Frame: 1, 2, 4, 8, and 12 weeks
For further exploration of reasons for the primary outcome we include a question regarding the general satisfaction with the web-application (10-0) and detailed questions/items regarding satisfaction with design (very, some, little, none), satisfaction with customisation (very, some, little, none ), satisfaction with usability (very, some, little, none ), satisfaction with readability (very, some, little, none), and satisfaction with credibility (very, some, little, none). It is only possible to tick off one box to each item, if the patient change decision while filling in the online questionnaire, another box can be ticked off and the first choice will automatically delete. Furthermore, these items will be validated against the primary outcome.
1, 2, 4, 8, and 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Allan Riis, PhD, Research unit for General Practice in Aalborg, Denmark

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 25, 2021

Primary Completion (Actual)

January 25, 2021

Study Completion (Actual)

January 25, 2021

Study Registration Dates

First Submitted

March 17, 2017

First Submitted That Met QC Criteria

March 17, 2017

First Posted (Actual)

March 23, 2017

Study Record Updates

Last Update Posted (Actual)

January 27, 2021

Last Update Submitted That Met QC Criteria

January 25, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AllanRiis_4

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Information material

3
Subscribe